Reprogramming resistance: phage-antibiotic synergy targets efflux systems in ESKAPEE pathogens

ABSTRACT Multidrug-resistant (MDR) and extensively drug-resistant (XDR) ESKAPE pathogens pose a significant global health threat due to their ability to evade antibiotics through intrinsic and acquired mechanisms. These bacteria, including Enterococcus faecium, Staphylococcus aureus, Klebsiella pneu...

Full description

Bibliographic Details
Published in:	mBio
Main Authors:	Anita Tarasenko, Bhavya N. Papudeshi, Susanna R. Grigson, Vijini Mallawaarachchi, Abbey L. K. Hutton, Morgyn S. Warner, Jeremy J. Barr, Jon Iredell, Bart Eijkelkamp, Robert A. Edwards
Format:	Article
Language:	English
Published:	American Society for Microbiology 2025-10-01
Subjects:	multidrug resistance (MDR) ESKAPEE pathogens phage therapy efflux pump inhibition phage-antibiotic synergy
Online Access:	https://journals.asm.org/doi/10.1128/mbio.01822-25

Similar Items

Molecular characterization of multidrug-resistant ESKAPEE pathogens from clinical samples in Chonburi, Thailand (2017–2018)
by: Sirigade Ruekit, et al.
Published: (2022-08-01)

Effectiveness of Efflux Pump Inhibitors as Biofilm Disruptors and Resistance Breakers in Gram-Negative (ESKAPEE) Bacteria
by: Akif Reza, et al.
Published: (2019-11-01)

Identification of clinically relevant multi-drug resistant ESKAPEE isolates from hospital wastewater surveillance in Thailand
by: Sidhartha Chaudhury, et al.
Published: (2025-09-01)

Combined Forces Against Bacteria: Phages and Antibiotics
by: Shima Afrasiabi, et al.
Published: (2025-07-01)

Isolation and characterization of phages ΦZC2 and ΦZC3 against carbapenem-resistant Acinetobacter baumannii, and efficacy of ΦZC3 on A549 cells
by: Kareem Essam, et al.
Published: (2025-07-01)

The Current Landscape of Phage–Antibiotic Synergistic (PAS) Interactions
by: Brittany S. I. Supina, et al.
Published: (2025-05-01)

Phage-Antibiotic Synergy: Enhancing Efficacy Against Multidrug-Resistant Bacteria
by: Anwer Faisal, et al.
Published: (2025-03-01)

Phage Therapy: Consider the Past, Embrace the Future
by: Junwei Wei, et al.
Published: (2020-10-01)

Antibacterial effect of phage cocktails and phage-antibiotic synergy against pathogenic Klebsiella pneumoniae
by: Mengshi zhao, et al.
Published: (2024-09-01)

Phage–Antibiotic Therapy as a Promising Strategy to Combat Multidrug-Resistant Infections and to Enhance Antimicrobial Efficiency
by: Chengxi Liu, et al.
Published: (2022-04-01)

Synergistic efficacy of phage Henu10 with antibiotics against Shigella dysenteriae with insight into phage resistance and fitness trade-offs
by: Jing Zhao, et al.
Published: (2024-12-01)

Temperate phage-antibiotic synergy is widespread—extending to Pseudomonas—but varies by phage, host strain, and antibiotic pairing
by: Rabia Fatima, et al.
Published: (2025-02-01)

Phage Therapy, a Salvage Treatment for Multidrug-Resistant Bacteria Causing Infective Endocarditis
by: Helal F. Hetta, et al.
Published: (2023-10-01)

Temperate phage-antibiotic synergy across antibiotic classes reveals new mechanism for preventing lysogeny
by: Amany M. Al-Anany, et al.
Published: (2024-06-01)

Thought on “Isolation and Phenotypic Characterization of Virulent Bacteriophages Against Multidrug-Resistant Escherichia Coli and Its Phage-Resistant Variant from Sewage Sources” [Letter]
by: Mardiana M, et al.
Published: (2024-05-01)

In Vitro Techniques and Measurements of Phage Characteristics That Are Important for Phage Therapy Success
by: Tea Glonti, et al.
Published: (2022-07-01)

Engineered endolysin of Klebsiella pneumoniae phage is a potent and broad-spectrum bactericidal agent against “ESKAPEE” pathogens
by: Wei Chen, et al.
Published: (2024-05-01)

An Optimized Checkerboard Method for Phage-Antibiotic Synergy Detection
by: Isidora Nikolic, et al.
Published: (2022-07-01)

From Isolation to Application: Utilising Phage‐Antibiotic Synergy in Murine Bacteremia Model to Combat Multidrug‐Resistant Enterococcus faecalis
by: Fatma Al‐zahraa A. Yehia, et al.
Published: (2025-01-01)

Temperate phages increase antibiotic effectiveness in a Caenorhabditis elegans infection model
by: Rabia Fatima, et al.
Published: (2025-09-01)

Schlesinger Nailed It! Assessing a Key Primary Pharmacodynamic Property of Phages for Phage Therapy: Virion Encounter Rates with Motionless Bacterial Targets
by: Stephen T. Abedon
Published: (2023-08-01)

Phage‐Antibiotic Combinations for Pseudomonas: Successes in the Clinic and In Vitro Tenuously Connected
by: Rabia Fatima, et al.
Published: (2025-07-01)

Effect of Phage SAvB14 combined with antibiotics on Staphylococcus aureus variant bovis
by: Y. V. Horiuk, et al.
Published: (2021-09-01)

Use of the Naturally Occurring Bacteriophage Grouping Model for the Design of Potent Therapeutic Cocktails
by: Tea Glonti, et al.
Published: (2024-04-01)

Evaluating the Role of Wastewaters as Reservoirs of Antibiotic-Resistant ESKAPEE Bacteria Using Phenotypic and Molecular Methods
by: Mustafa SS, et al.
Published: (2022-09-01)

Phage Therapy: Past، Present and Future
by: Farzaneh Fathi, et al.
Published: (2025-02-01)

Isolation and preliminary characterization of a novel bacteriophage vB_KquU_φKuK6 that infects the multidrug-resistant pathogen Klebsiella quasipneumoniae
by: Isaac P. Miller, et al.
Published: (2024-10-01)

Novel methods to design wild bacteriophages into highly lytic and therapeutic bacteriophages to extensively drug-resistant Mycobacterium tuberculosis
by: Ahmed S. Abdulamir
Published: (2016-10-01)

Overcoming phage resistance: efficacy of sequential phage-colistin therapy against carbapenem-resistant Acinetobacter baumannii
by: Yoon-Jung Choi, et al.
Published: (2025-10-01)

The Israeli Phage Bank (IPB)
by: Ortal Yerushalmy, et al.
Published: (2020-05-01)

The Resistome of ESKAPEE Pathogens in Untreated and Treated Wastewater: A Polish Case Study
by: Jakub Hubeny, et al.
Published: (2022-08-01)

Phage Cocktail in Combination with Kasugamycin as a Potential Treatment for Fire Blight Caused by <i>Erwinia amylovora</i>
by: Sang-Guen Kim, et al.
Published: (2022-11-01)

Phage Digestion of a Bacterial Capsule Imparts Resistance to Two Antibiotic Agents
by: Cheng-Hung Luo, et al.
Published: (2021-04-01)

<i>Klebsiella pneumoniae</i> Phage M198 and Its Therapeutic Potential
by: Lika Leshkasheli, et al.
Published: (2025-01-01)

Bacteria- and Phage-Derived Proteins in Phage Infection
by: Olga I. Guliy, et al.
Published: (2025-02-01)

Do Anti-Phage Antibodies Persist after Phage Therapy? A Preliminary Report
by: Marzanna Łusiak-Szelachowska, et al.
Published: (2022-10-01)

Comparison of bacterial suppression by phage cocktails, dual‐receptor generalists, and coevolutionarily trained phages
by: Joshua M. Borin, et al.
Published: (2023-01-01)

Aztreonam Lysine Increases the Activity of Phages E79 and phiKZ against <i>Pseudomonas aeruginosa</i> PA01
by: Carly M. Davis, et al.
Published: (2021-01-01)

Synergistic bactericidal activity of a naturally isolated phage and ampicillin against urinary tract infecting Escherichia coli O157
by: Zahra Moradpour, et al.
Published: (2020-02-01)

Study of the probability of resistance to phage infection in a collection of clinical isolates of Pseudomonas aeruginosa in relation to the presence of Pf phages
by: Lucía Blasco, et al.
Published: (2025-03-01)